CHIMIX CELL THERAPY Trademark

Trademark Overview

On Wednesday, February 22, 2023, a trademark application was filed for CHIMIX CELL THERAPY with the United States Patent and Trademark Office. The USPTO has given the CHIMIX CELL THERAPY trademark a serial number of 97806112. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 30, 2024. This trademark is owned by Medeor Acquisition Corp.. The CHIMIX CELL THERAPY trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Blood and bone marrow for medical purposes, namely, processed blood and bone marrow for preventing and treating rejection of transplanted kidneys, transplanted livers, transplanted hearts, and other transplanted organs; Blood and bone marrow for medical purposes, namely, processed blood and bone marrow for control and suppression of the immune system; Blood and bone marrow for medical purposes, namely, processed blood and bone marrow for induction of immune tolerance; Blood and bone marrow for medical purposes, namely, processed blood and bone marrow for treating and destroying cancer cells

Medical services, namely, processing blood and bone marrow to prevent and treat rejection of transplanted kidneys, transplanted livers, transplanted hearts, and other transplanted organs; Medical services, namely, processing blood and bone marrow for control and suppression of the immune system; Medical services, namely, processing blood and bone marrow for immune destruction of cancer cells; Medical services in the field of preventing and treating rejection of transplanted kidneys, transplanted livers, transplanted hearts, and other transplanted organs; Medical services in the field of control and suppression of the immune system; Medical services in the field of induction of immune tolerance; Medical services in the field of treating and destroying cancer cells; Medical testing for diagnostic or treatment purposes in the field of preventing and treating rejection of transplanted kidneys, transplanted livers, transplanted hearts, and other transplanted organs; Medical testing for diag...

Clinical research in the field of human diseases; research and development services in the field of immunology and hematology; scientific, medical, and biological research; research and development in the field of pharmaceutical products
chimix cell therapy

General Information

Serial Number97806112
Word MarkCHIMIX CELL THERAPY
Filing DateWednesday, February 22, 2023
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 30, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 2, 2024

Trademark Statements

Goods and ServicesBlood and bone marrow for medical purposes, namely, processed blood and bone marrow for preventing and treating rejection of transplanted kidneys, transplanted livers, transplanted hearts, and other transplanted organs; Blood and bone marrow for medical purposes, namely, processed blood and bone marrow for control and suppression of the immune system; Blood and bone marrow for medical purposes, namely, processed blood and bone marrow for induction of immune tolerance; Blood and bone marrow for medical purposes, namely, processed blood and bone marrow for treating and destroying cancer cells
Goods and ServicesMedical services, namely, processing blood and bone marrow to prevent and treat rejection of transplanted kidneys, transplanted livers, transplanted hearts, and other transplanted organs; Medical services, namely, processing blood and bone marrow for control and suppression of the immune system; Medical services, namely, processing blood and bone marrow for immune destruction of cancer cells; Medical services in the field of preventing and treating rejection of transplanted kidneys, transplanted livers, transplanted hearts, and other transplanted organs; Medical services in the field of control and suppression of the immune system; Medical services in the field of induction of immune tolerance; Medical services in the field of treating and destroying cancer cells; Medical testing for diagnostic or treatment purposes in the field of preventing and treating rejection of transplanted kidneys, transplanted livers, transplanted hearts, and other transplanted organs; Medical testing for diagnostic or treatment purposes in the field of control and suppression of the immune system blood analysis services
NOT AVAILABLE"CELL THERAPY"
Goods and ServicesClinical research in the field of human diseases; research and development services in the field of immunology and hematology; scientific, medical, and biological research; research and development in the field of pharmaceutical products

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, March 13, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, March 13, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, March 13, 2023
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMedeor Acquisition Corp.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NameMedeor Acquisition Corp.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events

Event DateEvent Description
Saturday, February 25, 2023NEW APPLICATION ENTERED
Monday, March 13, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, November 21, 2023ASSIGNED TO EXAMINER
Wednesday, November 22, 2023EXAMINERS AMENDMENT -WRITTEN
Wednesday, November 22, 2023EXAMINERS AMENDMENT E-MAILED
Wednesday, November 22, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, November 22, 2023EXAMINER'S AMENDMENT ENTERED
Wednesday, November 22, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 13, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 2, 2024PUBLISHED FOR OPPOSITION
Tuesday, January 2, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 27, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, September 30, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, September 30, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Related Keywords

therapy cell chimix transplanted medical marrow blood bone field services namely immune treating